 aims high profit fall saw profits fall biggest recovery way cheap copies drugs particularly weak dollar hit profits global sales firm confident new drug pipeline deliver profits despite failure obesity drug chief executive difficult early afternoon trade company price pence company absorbed lost sales generics managing grow business continuing success key products means look forward good performance important terms research development pipeline progress firm discontinued development experimental treatment obesity known disappointing clinical trial results relying new treatments conditions cancer diabetes depression allergies lift pace sales growth disappointing years